-
321por Carbone, Anna, Spanò, Virginia, Parrino, Barbara, Ciancimino, Cristina, Attanasi, Orazio A., Favi, Gianfranco“…Derivatives 10a,c–e, deazaanalogues of the bis-indole alkaloid topsentin, screened by the National Cancer Institute (Bethesda, MD, USA) in the in vitro one dose primary anticancer assay against a panel of about 60 human tumor cell lines, showed no significant activity, with the exception of compound 9e, which showed moderate activity against the HOP-92 cell line of the non small cell lung cancer sub-panel and the SNB-75 cell line of the CNS sub-panel.…”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
322por Parrino, Barbara, Spanò, Virginia, Carbone, Anna, Barraja, Paola, Diana, Patrizia, Cirrincione, Girolamo, Montalbano, Alessandra“…Derivatives of the title ring system were tested by the National Cancer Institute (Bethesda, MD, USA) and four of them exhibited modest activity against MCF7 (a breast cancer cell line) and/or UO-31 (a renal cancer cell line).…”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
323por Fahmy, Hoda H., Khalifa, Nagy M., Ismail, Magda M. F., El-Sahrawy, Hend M., Nossier, Eman S.“…With the aim of developing novel antitumor scaffolds, a novel series of polysubstituted pyrazole derivatives linked to different nitrogenous heterocyclic ring systems at the C-4 position were synthesized through different chemical reactions and characterized by means of spectral and elemental analyses and their antiproliferative activity against 60 different human tumor cell lines was validated by the U.S. National Cancer Institute using a two stage process. The in vitro anticancer evaluation revealed that compound 9 showed increased potency toward most human tumor cell lines with GI(50)MG-MID = 3.59 µM, as compared to the standard drug sorafenib (GI(50) MG-MID = 1.90 µM). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
324por Dafalla, Ameer Mohamed, Edinur, Hisham Atan, Abdelwahed, Mohammed, Elemam, Almutaz Abbas, Ibrahim, Amel Abdeen, Mohamadani, Ahmed, Magzoub, Mubarak, ElGhazali, Gehad“…The sampled individuals are all local transplant donors who provided informed consent for HLA analyses on their blood samples and were registered at National Cancer Institute, University of Gezira, Wad Medani. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
325por Kunos, Charles A., Capala, Jacek, Dicker, Adam P., Movsas, Benjamin, Ivy, Susan Percy, Minasian, Lori M.“…For nearly 40 years, the U.S. National Cancer Institute (NCI) has funded health-related quality-of-life (HRQOL) and symptom management in oncology clinical trials as a method for including a cancer patient's experience during and after treatment. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
326por Boja, Emily, Težak, Živana, Zhang, Bing, Wang, Pei, Johanson, Elaine, Hinton, Denise, Rodriguez, Henry“…To address a critical roadblock that can occur in translational and clinical research, the National Cancer Institute and the Food and Drug Administration, in coordination with the DREAM Challenges, are launching the first computational challenge using multi-omics datasets to detect and correct specimen mislabeling.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
327por Thomas, Stefani N., Friedrich, Betty, Schnaubelt, Michael, Chan, Daniel W., Zhang, Hui, Aebersold, Ruedi“…The National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) established a harmonized method for large-scale clinical proteomic studies. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
328“…The evaluation of antibody-targeted or peptide-targeted radiopharmaceuticals as monotherapy or in oncological drug combinations requires programmatic collaboration within the National Cancer Institute (NCI) clinical trial enterprise. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
329por Suneja, Gita, Mattes, Malcolm D., Mailhot Vega, Raymond B., Escorcia, Freddy E., Lawton, Colleen, Greenberger, Joel, Kesarwala, Aparna H., Spektor, Alexander, Vikram, Bhadrasain, Deville, Curtiland, Siker, Malika“…During the American Society of Radiation Oncology (ASTRO) 2019 Annual Meeting, ASTRO's Committee on Health Equity, Diversity, and Inclusion (CHEDI) and the National Cancer Institute (NCI) collaborated on the ASTRO-NCI Diversity Symposium, entitled "Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce." …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
330por Rein, Alan“…I was fortunate to be associated with the lab of Stephen Oroszlan at the US National Cancer Institute from ~1982 until his conversion to Emeritus status in 1995. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
331por Nitulescu, George Mihai“…A set of 1551 pyrazole derivatives were extracted from the National Cancer Institute (NCI) database, together with their growth inhibition effects (GI%) on the NCI’s panel of 60 cancer cell lines. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
332por Alves, Maria Nizete Tavares, Monteiro, Maria de Fátima Vasques, Alves, Fernanda Tavares, dos Santos Figueiredo, Francisco Winter“…We collected secondary data from Brazilian women with a diagnosis and without treatment from January to December 2019 through the Cancer Hospital Registers developed by the National Cancer Institute. Our findings indicate that most women (60.11%) are diagnosed with stage II cancer but are without treatment. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
333“…OBJECTIVES: The study aimed to determine whether the National Cancer Institute's (NCI) recent suggestion of associations between acrylonitrile (AN) exposure and mortality in lung and bladder cancer and pneumonitis is robust to alternative methods of data analysis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
334“…This paper presents a 2015–2021 US Food and Drug Administration (FDA) Drug Trials Snapshots (DTS) Data Visualization Explorer—an interactive data visualization web-based tool (https://arielcarmeli.shinyapps.io/fda-drug-trial-snapshots-data-explorer) built in R and based on publicly available FDA clinical trial participation data and disease incidence data from the National Cancer Institute and Centers for Disease Control and Prevention. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
335por Shy, C M“…A large study by the National Cancer Institute found that there had been a change in the source of raw water for 50% of the persons in one area between the years 1955 and 1975. …”
Publicado 1985
Enlace del recurso
Enlace del recurso
Texto -
336“…Four strains of mice—Harvard, Schwentker, CFW (Carworth Farms), and C (National Cancer Institute)—have been kept and bred underidentical conditions over the course of a year in order to determine the effect of strain, of litter, and of season upon the incidence of diarrheal disease among the suckling mice. 1. …”
Enlace del recurso
Enlace del recurso
Texto -
337“…We illustrate our proposed methods with an analysis of spatially oriented breast cancer survival data from the Surveillance, Epidemiology and End Results program of the National Cancer Institute. Our results indicate appreciable advantages for our approach over competing methods that impose unrealistic parametric assumptions, ignore spatial association or both.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
338A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopmentpor Taube, Sheila E., Clark, Gary M., Dancey, Janet E., McShane, Lisa M., Sigman, Caroline C., Gutman, Steven I.“…A workshop sponsored by the National Cancer Institute and the US Food and Drug Administration addressed past lessons learned and ongoing challenges faced in biomarker development and drug and biomarker codevelopment. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
339“…We analyzed data from a subset of respondents (N = 1,994) in the National Cancer Institute's Food Attitudes and Behaviors Survey, a mail survey of US adults. …”
Enlace del recurso
Enlace del recurso
Texto -
340“…Three epigenetic drugs are already arriving at the patient’s bedside, and more than 100 clinical assays for HDACi are registered on the National Cancer Institute website. They explore the eventual additive benefits of combined therapies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto